South and Central America Sequencing Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Next Generation Sequencing, Sanger Sequencing, and Third Generation Sequencing), Application (Agrigenomics and Forensics, Clinical Investigation, Oncology, Reproductive Health, and Other Applications), Reagent Type (Control Kits, Library Kits, Template Kits, Sequencing Kits, and Other Reagent Types), and End User (Hospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End Users)
Market Introduction
Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well.
Get more information on this report :
Market Overview and Dynamics
The South and Central America sequencing reagents market is expected to reach US$ 737.60 million by 2028 from US$ 342.80 million in 2021; it is estimated to grow at a CAGR of 11.6% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as the increasing volume of funding activities for various research studies and the declining cost of sequencing procedures. However, the dearth of skilled professionals hinders the market growth.
Sequencing form an essential part of the sequencing reactions, which can be used across various other applications as well. Now, sequencing reagents is increasingly used in clinical practice, and over the next five years, genomic data from over 60 million patients is expected to be generated within healthcare. Genomic sequencing is rapidly transitioning into clinical practice, and implementation into healthcare systems has been supported by substantial government investment, totaling over US$ 4 billion in at least 14 countries. These national genomic-medicine initiatives are driving transformative change under real-life conditions while simultaneously addressing barriers to implementation and gathering evidence for broader adoption, thereby driving the growth of the sequencing reagent market. In addition, continuous funding by manufacturers and governments in the field of genomics is expected to bolster the market growth during the forecast period. In the recent years, next generation sequencing price have declined substantially. Owing to factors such as advances in the field of genomics and developments in different methods and strategies for sequencing, there is a notable decline in the cost of sequencing, which is propelling the market growth.
With the second wave of COVID-19 outbreak, there has been an increasing number of confirmed cases in Latin American countries. Currently, Brazil is rapidly increasing its clinical programs to fight against the novel coronavirus. There is a rising focus on genomic sequencing and tests. For instance, in July 2020, Vale Institute of Technology (ITV) and Fiocruz announced that they are planning to carry out the most extensive genome sequencing study of the Sars-CoV-2. Vale invested R$ 2.4 million in the research. Such initiatives would bolster the growth of the South and Central America sequencing reagents market in long run.
Key Market Segments
The South and Central America sequencing reagents market, by technology, is segmented into next generation sequencing, sanger sequencing, and third generation sequencing. The next generation sequencing segment held the largest share of the market in 2020. However, the sanger sequencing segment is anticipated to register the highest CAGR in the market during the forecast period.
The South and Central America sequencing reagents market, by reagent type, is segmented into control kits, library kits, template kits, sequencing kits, and other reagent types. The sequencing kits segment held the largest share of the market in 2020, whereas the library kits segment is anticipated to register the highest CAGR in the market during the forecast period.
The South and Central America sequencing reagents market, by application, is segmented into agrigenomics and forensics, clinical investigation, oncology, reproductive health, and other applications. The oncology segment held the largest share of the market in 2020. However, the clinical investigation segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on end user, the South and Central America sequencing reagents market is segmented into hospitals and clinics, research institutes, and pharmaceutical and biotechnology companies, and other end users. The research institutes segment held the largest share of the market in 2020. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the South and Central America sequencing reagents market are American Society of Clinical Oncology (ASCO), American Society of Human Genomics (ASCG) and International Atomic Energy Agency (IAEA).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of South and Central America sequencing reagents market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the South and Central America sequencing reagents market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America sequencing reagents market.
SOUTH AND CENTRAL AMERICA SEQUENCING REAGENTS MARKET SEGMENTATION
By Technology
- Next Generation Sequencing
- Sanger Sequencing
- Third Generation Sequencing
By Reagent Type
- Control Kits
- Library Kits
- Template Kits
- Sequencing Kits
- Other Reagent Types
By Application
- Agri genomics and Forensics
- Clinical Investigation
- Oncology
- Reproductive Health
- Other Applications
By End User
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Other End Users
By Country
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- QIAGEN
- Takara Bio Inc.
- THERMO FISHER SCIENTIFIC INC.
- TriLink BioTechnologies Inc
- F. HOFFMANN-LA ROCHE LTD.
- Illumina, Inc.
- FLUIDIGM CORPORATION
- LGC Biosearch Technologies
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.4 Market Segmentation
1.4.1 South and Central America Sequencing Reagents Market – By Technology
1.4.2 South and Central America Sequencing Reagents Market – By Reagent Type
1.4.3 South and Central America Sequencing Reagents Market – By Application
1.4.4 South and Central America Sequencing Reagents market – By End User
1.4.5 South and Central America Sequencing Reagents market – By Country
2. Sequencing Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Sequencing Reagents Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Sequencing Reagents Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Declining Cost of Sequencing Procedures
5.1.3 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increasing Demand for Third Generation Sequencing
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact analysis
6. Sequencing Reagents Market – South and Central America Analysis
6.1 South and Central America Sequencing Reagents Market Revenue Forecast and Analysis
7. Sequencing Reagents Market Analysis – By Technology
7.1 Overview
7.2 Sequencing Reagents Market Revenue Share, by Technology (2020 and 2028)
7.3 Next Generation Sequencing
7.3.1 Overview
7.3.2 Next Generation Sequencing: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Sanger Sequencing
7.4.1 Overview
7.4.2 Sanger Sequencing: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Third Generation Sequencing
7.5.1 Overview
7.5.2 Third Generation Sequencing: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. Sequencing Reagents Market Analysis – By Reagent Type
8.1 Overview
8.2 Sequencing Reagents Market Revenue Share, by Reagent Type (2020 and 2028)
8.3 Control Kits
8.3.1 Overview
8.3.2 Control Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Library Kits
8.4.1 Overview
8.4.2 Library Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Template Kits
8.5.1 Overview
8.5.2 Template Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Sequencing Kits
8.6.1 Overview
8.6.2 Sequencing Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Other Reagent Types
8.7.1 Overview
8.7.2 Other Reagent Types: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. Sequencing Reagents Market Analysis – By Application
9.1 Overview
9.2 Sequencing Reagents Market Revenue Share, by Application (2020 and 2028)
9.3 Agrigenomics and Forensics
9.3.1 Overview
9.3.2 Agrigenomics And Forensics: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Clinical Investigation
9.4.1 Overview
9.4.2 Clinical Investigation: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Reproductive Health
9.6.1 Overview
9.6.2 Reproductive Health: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Other Applications
9.7.1 Overview
9.7.2 Other Applications: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. Sequencing Reagents Market Analysis – By End User
10.1 Overview
10.2 Sequencing Reagents Market Share, by End User, 2020 and 2028, (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Research Institutes
10.4.1 Overview
10.4.2 Research Institutes: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Pharmaceutical and Biotechnology Companies
10.5.1 Overview
10.5.2 Pharmaceutical and Biotechnology Companies: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
10.6.1 Overview
10.6.2 Other End Users: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
11. Sequencing Reagents Market – South and Central America Analysis
11.1 South and Central America: Sequencing Reagents Market
11.1.1 Overview
11.1.2 South and Central America: Sequencing Reagents Market, by Country, 2020 & 2028 (%)
11.1.3 Brazil: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
11.1.3.1 Brazil: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
11.1.3.2 Brazil: Sequencing Reagents Market, by Technology, 2019–2028 (USD Million)
11.1.3.3 Brazil: Sequencing Reagents Market, by Reagent Type, 2019–2028 (USD Million)
11.1.3.4 Brazil: Sequencing Reagents Market, by Application, 2019–2028 (USD Million)
11.1.3.5 Brazil: Sequencing Reagents Market, by End-User, 2019–2028 (USD Million)
11.1.4 Argentina: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
11.1.4.1 Argentina: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
11.1.4.2 Argentina: Sequencing Reagents Market, by Technology, 2019–2028 (USD Million)
11.1.4.3 Argentina: Sequencing Reagents Market, by Reagent Type, 2019–2028 (USD Million)
11.1.4.4 Argentina: Sequencing Reagents Market, by Application, 2019–2028 (USD Million)
11.1.4.5 Argentina: Sequencing Reagents Market, by End-User, 2019–2028 (USD Million)
11.1.5 Rest of South and Central America: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
11.1.5.1 Rest of South and Central America: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
11.1.5.2 Rest of South and Central America: Sequencing Reagents Market, by Technology, 2019–2028 (USD Million)
11.1.5.3 Rest of South and Central America: Sequencing Reagents Market, by Reagent Type, 2019–2028 (USD Million)
11.1.5.4 Rest of South and Central America: Sequencing Reagents Market, by Application, 2019–2028 (USD Million)
11.1.5.5 Rest of South and Central America: Sequencing Reagents Market, by End-User, 2019–2028 (USD Million)
12. Impact of COVID-19 Pandemic on South and Central America Sequencing Reagents Market
12.1 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Sequencing Reagents Market –Industry Landscape
13.1 Overview
13.2 Organic Growth Strategies
13.2.1 Overview
13.3 Inorganic Growth Strategies
13.3.1 Overview
14. Company Profiles
14.1 QIAGEN
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Takara Bio Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 THERMO FISHER SCIENTIFIC INC.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 TriLink BioTechnologies Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 F. HOFFMANN-LA ROCHE LTD.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Illumina, Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 FLUIDIGM CORPORATION
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 LGC Biosearch Technologies
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil Sequencing Reagents Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Sequencing Reagents Market, by Reagent Type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Sequencing Reagents Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Sequencing Reagents Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina Sequencing Reagents Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Sequencing Reagents Market, by Reagent Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Sequencing Reagents Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Sequencing Reagents Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South and Central America Sequencing Reagents Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South and Central America Sequencing Reagents Market, by Reagent Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South and Central America Sequencing Reagents Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South and Central America Sequencing Reagents Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 13. Recent Organic Developments in the Sequencing Reagents Market
Table 14. Recent Inorganic Developments in The Sequencing Reagents Market
Table 15. Glossary of Terms, Sequencing Reagents Market
LIST OF FIGURES
Figure 1. Sequencing Reagents Market Segmentation
Figure 2. Sequencing Reagents Market Segmentation, By Country
Figure 3. Sequencing Reagents Market Overview
Figure 4. Next Generation Sequencing Held Largest Share by Technology of Sequencing Reagents Market
Figure 5. South and Central America Sequencing Reagents Market – Leading Country Markets (US$ Million)
Figure 6. South and Central America (SCAM) PEST Analysis
Figure 7. Sequencing Reagents Market Impact Analysis of Drivers and Restraints
Figure 8. South and Central America Sequencing Reagents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Sequencing Reagents Market Revenue Share, by Technology (2020 and 2028)
Figure 10. Next Generation Sequencing: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Sanger Sequencing: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Third Generation Sequencing: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Sequencing Reagents Market Revenue Share, by Reagent Type (2020 and 2028)
Figure 14. Control Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Library Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Template Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Sequencing Kits: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Other Reagent Types: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Sequencing Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. Agrigenomics And Forensics: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Clinical Investigation: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Oncology: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Reproductive Health: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Other Applications: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Sequencing Reagents Market Share, by End User, 2020 and 2028 (%)
Figure 26. Hospitals and Clinics: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Research Institutes: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Pharmaceutical and Biotechnology Companies: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Other End Users: Sequencing Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. South and Central America: Sequencing Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 31. South and Central America: Sequencing Reagents Market, by Country, 2020 & 2028 (%)
Figure 32. Brazil: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
Figure 33. Argentina: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
Figure 34. Rest of South and Central America: Sequencing Reagents Market– Revenue and Forecast to 2028 (USD Million)
Figure 35. Impact of COVID-19 Pandemic in South & Central America Market
- QIAGEN
- Takara Bio Inc.
- THERMO FISHER SCIENTIFIC INC.
- TriLink BioTechnologies Inc
- F. HOFFMANN-LA ROCHE LTD.
- Illumina, Inc.
- FLUIDIGM CORPORATION
- LGC Biosearch Technologies
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America sequencing reagents market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America sequencing reagents market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.